InterContinental Hotels Group PLC

IHG's profit is expected to grow by 37% over the next couple of years, with higher cash flows likely feeding into a higher share valuation. Goldman Sachs raised its price target to $190 and BofA Securities to $188, citing stronger Americas trends and RevPAR growth, suggesting the premium valuation is justified by strong fundamentals.

IHG appears overvalued by approximately 35%, with the stock trading at $169 versus an estimated intrinsic value of $125.28. Deutsche Bank maintains a Hold rating with a price target of $145, well below market price, and InvestingPro data similarly flags the stock as overvalued relative to its Fair Value estimate.

Deutsche Bank projects RevPAR growth of approximately 4% for first-half 2026, driven by accelerating U.S. performance of 4.5% in Q2. BofA Securities forecasts 3.1% RevPAR growth for Q2, while Goldman Sachs revised its full-year RevPAR forecast upward, reflecting confidence in the company's geographic diversification and demand resilience.

Despite solid U.S. momentum, Deutsche Bank flags deceleration in Europe, Middle East, Africa and Asia, as well as Greater China — IHG's key international growth markets. This regional divergence raises concerns about whether global RevPAR growth can be sustained, especially amid ongoing geopolitical challenges.

A minority but notable group of analysts maintains strong conviction in IHG's upside. Barclays raised its target to 19,100 pence with an 'overweight' rating, and Goldman Sachs and BofA Securities both set targets well above current prices, reflecting optimism about IHG's strategic direction, brand expansion, and net system growth.

The broader analyst community leans cautious, with 50% of 26 analysts recommending a Sell rating and an average price target of $142.33 — implying roughly 11% downside from current levels. The consensus Hold rating and limited recent research coverage further reflect skepticism about near-term upside potential.